TTC8

Across TCGA pan-cancer cohorts, TTC8 mass-spec protein differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of TTC8’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where TTC8 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types TTC8 is over-expressed in tumor, although a few such as LSCC and LUAD show the opposite, repressed pattern.

LSCC, LUAD, and HNSC are the cancer types where TTC8 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in TTC8 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LSCC	Female	All	−0.616	<.001	8	view →
LUAD	Female	II,III,IV	−0.314	<.001	8	view →
HNSC	Male	II,III,IV	−0.463	<.001	6	view →
CCRCC	Female	All	−0.226	.003	6	view →
PDAC	All	All	+0.362	.002	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

TTC8–LSCC

Open the LSCC breakdown →